No Data
There May Be Some Bright Spots In Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings
Wonder Pharmaceuticals: Shanghai Magic Pharmaceutical Investment Management Co., Ltd. Report for the Third Quarter of 2024
Shanghai Magic Pharmaceutical Investment Management Co., Ltd. Report for the Third Quarter of 2024
Shanghai Magic Pharmaceutical Investment Management Co., Ltd. announced the main operating data for the third quarter of 2024
shanghai shenqi pharmaceutical investment management (600613.SH) released its performance for the first three quarters, with a net income of 59.3538 million yuan, a decrease of 10% year-on-year.
shanghai shenqi pharmaceutical investment management (600613.SH) released the report for the first three quarters of 2024, during which the company achieved revenue...
Shanghai Shenqi Pharmaceutical Investment Management (600613.SH): net income for the first three quarters was 59.3538 million yuan, a 10% decrease year-on-year.
Gelonghui October 30th | Shanghai Shenqi Pharmaceutical Investment Management (600613.SH) announced that in the first three quarters of 2024, revenue decreased by 8.61% year-on-year to 1.563 billion yuan; the net income attributable to the shareholders of the listed company decreased by 10.00% to 59.3538 million yuan, with basic earnings per share of 0.11 yuan.
More Unpleasant Surprises Could Be In Store For Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) Shares After Tumbling 26%No Data
No Data
